ストックスクリーナーアプリを入手
7.85
29.86%
1.805
前日終値:
$6.045
開ける：
$6.39
24時間の取引高:
989.71K
Relative Volume:
1.30
時価総額：
$7.07M
収益：
-
当期純損益:
$-8.22M
株価収益率:
-1.0543
EPS:
-7.4459
ネットキャッシュフロー:
$-4.78M
1週間 パフォーマンス:
+96.25%
1か月 パフォーマンス:
+212.13%
6か月 パフォーマンス:
+126.22%
1年 パフォーマンス:
+89.16%
1日の値動き範囲:
$5.6342
$7.85
1週間の範囲:
$3.50
$7.85
52週間の値動き範囲:
$1.84
$7.85
Synaptogenix Inc Stock (SNPX) Company Profile
名前
Synaptogenix Inc
セクター
電話
(973) 242-0005
住所
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK
SNPX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SNPX
Synaptogenix Inc
|
7.85 | 7.07M | 0 | -8.22M | -4.78M | -7.4459 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.44 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
534.87 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
321.01 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
557.86 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
242.58 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Synaptogenix Inc (SNPX) 最新ニュース
Small-cap healthcare stocks with explosive potential - businessnewsthisweek.com
bioAffinity Technologies Stock Price, Quotes and Forecasts | NASDAQ:BIAF - Benzinga
Pre-market Movers: HCTI, KLTO, INTS, HSDT... - RTTNews
This cryptocurrency breaks into the elite of digital assets used as reserves in corporate treasuries. - Bit2Me News
TAO Is Next for Corporate Treasury, Nasdaq Giants Fuel Bittensor’s 10% Rally - Coinspeaker
Bittensor (TAO) Becomes the Next Pick in the Wave of Public Crypto Treasuries - BeInCrypto
Health Care Sector Sees Mixed Results And Strategic Moves - Finimize
Synaptogenix pumps $100m into artificial intelligence token - Mugglehead Magazine
Klotho Neurosciences Sees Massive Jump After Promising Gene Study - Finimize
Synaptogenix (SNPX) Unveils AI-Focused Cryptocurrency Strategy | SNPX Stock News - GuruFocus
Synaptogenix, Inc. announced that it expects to receive $5.5 million in funding - MarketScreener
Synaptogenix Unveils TAO-Focused Crypto Treasury Plan - Live Bitcoin News
Synaptogenix Appoints James Altucher to Lead Digital Asset Treasury Strategy - citybiz
Synaptogenix Says On June 8, Alan Tuchman Resigned As CEO And Director Of Co - MarketScreener
Synaptogenix Launch Of Differentiated Cryptocurrency Treasury Strategy Focused Exclusively On AI Crypto Token 'TAO' - marketscreener.com
Synaptogenix Stock Soars on Bold AI Crypto Bet - RagingBull
Synaptogenix Announces $5.5M Securities Purchase Agreement - TipRanks
Synaptogenix Appoints Crypto Expert to Lead Digital Asset Treasu - GuruFocus
Synaptogenix Appoints Crypto Expert to Lead Digital Asset Treasury Strategy Focused Exclusively on Top-Valued AI Token | SNPX Stock News - GuruFocus
First Pure-Play AI Crypto Stock: Synaptogenix Commits $100M to Leading AI Token TAO, Appoints Crypto Expert - Stock Titan
Full Stock Market News from 2025-06-06 - Stock Titan
Synaptogenix, Inc. (NASDAQ:SNPX) Short Interest Update - Defense World
Synaptogenix (NASDAQ:SNPX) Trading 1.5% Higher – Here’s What Happened - Defense World
Full Stock Market News from 2025-05-27 - Stock Titan
Full Stock Market News from 2025-05-22 - Stock Titan
SNPXSynaptogenix Latest Stock News & Market Updates - Stock Titan
Geode Capital Management LLC Takes $39,000 Position in Synaptogenix, Inc. (NASDAQ:SNPX) - Defense World
Synaptogenix stock plunges to 52-week low of $2.14 By Investing.com - Investing.com Canada
Synaptogenix stock plunges to 52-week low of $2.14 - Investing.com Australia
Synaptogenix Inc. (SNPX) reports earnings - qz.com
Will Synaptogenix Make A Mark In Synaptic Regeneration? - RTTNews
Synaptogenix stock hits 52-week low at $2.15 amid market challenges - Investing.com Australia
Synaptogenix stock hits 52-week low at $2.15 amid market challenges By Investing.com - Investing.com South Africa
Ensysce Biosciences Stock Price, Quotes and Forecasts | NASDAQ:ENSC - Benzinga
Synaptogenix (NASDAQ:SNPX) Trading Down 0.3% – Here’s Why - Defense World
Sonnet BioTherapeutics Stock Price, Quotes and Forecasts - Benzinga
Mustang Bio Stock Price, Quotes and Forecasts | NASDAQ:MBIO - Benzinga
Aptevo Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:APVO - Benzinga
ZyVersa Therapeutics (NASDAQ:ZVSA) Stock Quotes, Forecast and News Summary - Benzinga
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.18% - MSN
Finance Watch: As Cash Dwindles, Biotechs Cut Costs, Sell Assets, Merge, Assess Options - News & Insights
Synaptogenix Forms Special Committee to Explore Value Creation Opportunities Utilizing Balance Sheet Strength - Marketscreener.com
Synaptogenix (SNPX) Extends CEO’s Employment and Forms Special Committee to Explore Strategic Opportunities - Defense World
Synaptogenix Forms Special Committee to Explore Strategic Options with $19.6M Cash Runway - StockTitan
Informatica Leads Gartner Magic Quadrant for Data Integration Tools for 19th Straight Year - Stock Titan
Synaptogenix appoints new auditor as Morison Cogen exits - Investing.com
Synaptogenix Announces $5.0 Million Financing - citybiz
Polyrizon Stock Price, Quotes and Forecasts | NASDAQ:PLRZ - Benzinga
Synaptogenix cleared to launch Phase 1 trial of bryostatin-1 in MS - Multiple Sclerosis News Today
FDA grants IND authorisation for Synaptogenix’s multiple sclerosis trial - Clinical Trials Arena
Synaptogenix Inc (SNPX) 財務データ
収益
当期純利益
現金流量
EPS
0.12%
1.89%
大文字化:
|
ボリューム (24 時間):